The impending financial healthcare burden and ethical dilemma of systemic therapy in metastatic cancer-Reference-Cited by-同舟云学术

The impending financial healthcare burden and ethical dilemma of systemic therapy in metastatic cancer

Published:2016-07-04 Issue:3 Volume:114 Page:323-328
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J. Surg. Oncol.

Author:

Riaz Muhammad Kashif¹,Bal Susan¹,Wise-Draper Trisha²

Affiliation:

1. Division of Hematology/Oncology; University of Cincinnati Medical Center; Cincinnati Ohio

2. Assistant Professor of Medicine, Division of Hematology/Oncology, Head and Neck Oncology/Experimental Therapeutics, Associate Hematology/Oncology Fellowship Director; University of Cincinnati Cancer Institute; Cincinnati Ohio

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Reference47 articles.

1. Hematology/oncology (cancer) approvals & safety notifications http://www.fda.gov/drugs/informationondrugs/approveddrugs/ucm279174.htm

2. Munro D http://www.forbes.com/sites/danmunro/2015/01/04/u-s-healthcare-spending-on-track-to-hit-10000-per-person-this-year/

3. National health expenditure projections, 2014-24: Spending growth faster than recent trends;Keehan;Health Aff,2015

4. Space.com 2012 http://www.space.com/16918-nasa-mars-human-spaceflight-goals.html

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brain Metastases and Microenvironment;Advances in Experimental Medicine and Biology;2021

2. Ethical Challenges in Cancer Care: A Qualitative Analysis of Nurses' Perceptions;Research and Theory for Nursing Practice;2019-05-01

3. Financial Toxicity Among Women With Metastatic Breast Cancer;Oncology Nursing Forum;2018-12-21

4. Concern over cost of and access to cancer treatments: A meta-narrative review of nivolumab and pembrolizumab studies;Critical Reviews in Oncology/Hematology;2018-09

5. A Quininib Analogue and Cysteinyl Leukotriene Receptor Antagonist Inhibits Vascular Endothelial Growth Factor (VEGF)-independent Angiogenesis and Exerts an Additive Antiangiogenic Response with Bevacizumab;Journal of Biological Chemistry;2017-03